Position in DXCM
as of Mar 31, 2026
· filed May 28, 2026
Position Value
$5,652,000
-$12,722,545 QoQ
Shares Held
90,000
-57.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Avidity Partners Management LP holds $46,435,595 across 6 Medical Devices names. DXCM ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CATX |
Perspective Therapeutics, Inc.
|
6,049,999 | $25,228,495 | |
| 2 | MDT |
Medtronic plc
|
100,000 | $8,665,000 | |
| 3 | DXCM |
Dexcom Inc
This page
|
90,000 | $5,652,000 | |
| 4 | BSX |
Boston Scientific Corp
|
60,000 | $3,765,000 | |
| 5 | PODD |
Insulet Corp
|
10,000 | $2,098,400 | |
| 6 | ABT |
Abbott Laboratories
|
10,000 | $1,026,700 |
All Filings in DXCM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,652,000 | 90,000 | Shares | Sole | 2026-05-28 | |
| 2025-06-30 | $18,374,545 | 210,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,292,200 | 180,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,730,860 | 318,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,089,600 | 240,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $29,365,420 | 259,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,536,030 | 176,900 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $35,239,410 | 377,700 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $17,194,640 | 148,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $85,700,032 | 756,800 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $37,660,504 | 467,600 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||